Abstract

BackgroundPim-1 is a serine-threonine kinase which promotes early transformation, cell proliferation and cell survival during tumorigenesis. Several studies have demonstrated that Pim-1 kinase play a role in different cancer types, however, the function of Pim-1 in bladder cancer is poorly understood.MethodsExpression and localization of Pim-1 in human normal and malignant bladder specimens were examined by Immunohistochemistry and Pim-1 staining score was compared with several clinicopathologic parameters. To further demonstrate the biological function of Pim-1 in bladder cancer, its expression was validated in five bladder cancer cell lines by western blot and immunohistochemistry analyses. Subsequent knockdown of Pim-1 was achieved by lentivirus encoding small interfering RNA, and the effect of Pim-1 on bladder cell survival and drug sensitivity were further assessed by colony formation and cell proliferation assays.ResultsWhen compared with normal epithelium, Pim-1 was overexpressed in bladder cancer epithelium, and the expression level was higher in invasive bladder cancer than Non-invasive bladder cancer specimens. Pim-1 was also detected in all the bladder cancer cell lines examined in our study. Moreover, the knockdown of Pim-1 significantly inhibited bladder cancer cell growth and also sensitized cells to chemotherapeutic drugs in vitro.ConclusionsOur results in this study suggest that Pim-1 may play a role in bladder cancer initiation and progression. Since Pim-1 is also involved in bladder cancer cell survival and drug resistance, Pim-1 is a potential candidate for targeted therapy in bladder cancer.

Highlights

  • Pim-1 is a serine-threonine kinase which promotes early transformation, cell proliferation and cell survival during tumorigenesis

  • Overexpression of Pim-1 in human bladder cancer specimens To validate the expression of Pim-1 protein in bladder cancer, human bladder specimens containing normal epithelium (n = 21) and malignant tissues (n = 45) were studied by immunohistochemistry using Pim-1 antibody

  • The staining data showed that Pim-1 expression is weakely detect in the epithelial cells of normal bladder epithelium, most of the malignant bladder epithelial cells exhibited Pim-1 immunoreactivity in both cytoplasm and nuclear (Figure 1)

Read more

Summary

Introduction

Pim-1 is a serine-threonine kinase which promotes early transformation, cell proliferation and cell survival during tumorigenesis. An average of 10% to 20% for Non-invasive tumors may further progress to muscle-invasive disease, lead to eventual radical Cystectomy and urinary diversion [1,2,3]. In this context, clinicians face challenges to identify the novel therapeutic targets for bladder cancer. As a member of serine/threonine kinase family, Pim-1 has multiple roles in tumorigenesis such as promoting transformation and cell proliferation partly through regulation of cell cycle and transcription by phosphorylating of number of substrates including cdc25A/C, HP1, and p100 [9,10,11]. The aims of the present study are to investigate the expression level of Pim-1 in bladder cancer tissue and study its function in the pathogenesis and progression of bladder cancer

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call